The Higher Standards of the European Pharmacopoeia

EDQM - European Pharmacopoeia
Dr Agnès Artiges PhD

By Dr Agnès Artiges PhD, Director of the European Directorate for the Quality of Medicines, EDQM - European Pharmacopoeia

View Author Profile

The standards of the European Pharmacopoeia are designed to meet the needs of licensing authorities, public or private quality control laboratories as well as manufacturers of raw materials and pharmaceutical products.

The published texts enter into force on the same date in all the 30 states, which are Parties to the Convention; this date is chosen on the basis of a proposal by the European Pharmacopoeia Commission and is the subject of a Resolution (AP/CSP) of the Public Health Committee.

The 4th Edition of the European Pharmacopoeia replaced the 3rd Edition on 1 January 2002.

It includes all the texts of the revised 3rd Edition and the new texts adopted since 2000. The 4th Edition includes the following major changes in comparison with the previous edition. The style has been simplified to make it easier to use.

The collection of general monographs covering the various types of medicinal substances and preparations has been expanded. Many monographs have been modernised. Whenever possible certain dangerous reagents have been eliminated. More alternative methods have been added to replace the use of animals for potency testing for biological preparations.

These modifications are the result of extensive collaborative studies involving experts from the national control laboratories, universities and industries at the request of the EDQM, the European Pharmacopoeia Commission, and the licensing authorities (the EMEA in particular).

The 4th Edition is available in printed, CD-ROM or Internet versions, in English and in French.

The 4th Edition printed version, is expanded and updated by non-cumulative supplements published every 4 months to keep pace with accelerating regulatory and technical change. Three non-cumulative supplements are published per year, adding new or revised texts to those of the initial volume and previously published supplements.

The CD-ROM version is cumulative, when a new update is released (three CD-ROMs a year) it supersedes the previous one. It is available in English or French or both, for single users or intranet users. The information is displayed using a Web browser.

The Internet version is also cumulative and automatically updated three times a year. Like the CD-ROM version the information is displayed using a Web browser. A demonstration version is available at www.pheur.org. The internet version is bilingual only.

The entire European Pharmacopoeia can be consulted using a hierarchic table of contents and keyword search. Hyperlinks in the text of a monograph connect to general texts such as general methods, reagents and also to the online database for reference substances.

Official texts implemented at the same date
The implementation date for the texts of the 4th Edition is 1 January 2002. The implementation dates for the supplements are published on the our website www.pheur.org (4.1: 1 April 2002, 4.2: 1 July 2002, 4.3: 1 January 2003 etc.) whatever the version (Printed, CD-ROM or Internet).

How to contact us:

European Directorate for the Quality of Medicines (EDQM)
European Pharmacopoeia
226, avenue de Colmar BP 907
F – 67029 STRASBOURG Cedex 1
France

By telephone:

Publications: +33 (0)3 88 41 20 36
Reference substances: +33 (0)3 88 41 20 35
By Fax: +33 (0)3 88 41 27 71

By E-mail: info@pheur.org

Dr Agnès Artiges PhD

Author Information - Dr Agnès Artiges PhD

Director of the European Directorate for the Quality of Medicines

Dr Agnès Artiges graduated in pharmacy and has a PhD in the same subject, as well as a degree and a PhD in law, the latter from the University of Paris, France. In her postgraduate law degree she specialised in European Institutions.
She was Assistant and Assistant Instructor in the Toxicology Laboratory of the Faculty of Pharmacy of Bordeaux before joining the French Ministry of Health in 1971. During her career with the Ministry, she has held the posts of Head of the French Pharmacopoeia, Head of the Registration Authority for Medicinal Products for Human Use and Head of the Sub-directorate of Scientific and Technical Affairs.
In addition, she was Chairman of the European Pharmacopoeia Commission from November 1989 to November 1992 and a member of the former Quality Working Party of the Committee for Proprietary Medicinal Products (CPMP) of the EC and was Chairman of this Working Party from December 1991 to March 1993.
Dr Artiges left the French Ministry of Health in April 1993 to take up the post of Director of the European Directorate for the Quality of Medicines (European Pharmacopoeia and European Network of Official Medicines Control Laboratories/OMCL) - Council of Europe.

RSS